US FDA COVID Funds Move Forward In Congress, No Strings Attached

 
• By Derrick Gingery

Amendment to require one-firth of the money be devoted to therapeutic review was defeated by the House Energy and Commerce Committee.

Capitol-building-dome-light
A debate of adding funding for NIH also put Democrats in an awkward position. • Source: Shutterstock

More from Legislation

More from Pink Sheet